Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to make hypericin water-soluble.

A Kubin1, H G Loew, U Burner

  • 1Wiener Gesellschaft für PDD und PDT, Vienna, Austria. akubin@planta.at

Die Pharmazie
|May 13, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On De Giorgi's conjecture of nonlocal approximations for free-discontinuity problems: The symmetric gradient case.

Calculus of variations and partial differential equations·2026
Same author

[Treatment of Chronic Functional Constipation during Pregnancy and Lactation].

Zeitschrift fur Geburtshilfe und Neonatologie·2016
Same author

Computerized in vivo classification of methylene blue stained fallopian tube mucosal damage: preliminary results.

Clinical and experimental obstetrics & gynecology·2014
Same author

Maternal sepsis due to Clostridium perfringens after 2nd-trimester genetic amniocentesis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011
Same author

Fabric-mechanical property relationships of trabecular bone allografts are altered by supercritical CO₂ treatment and gamma sterilization.

Bone·2011
Same author

Treatment of intrauterine fetal death by means of a PGE2-filled portio adapter.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2006
Same journal

Comparative <i>In Vitro</i> Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product Switching.

Die Pharmazie·2026
Same journal

The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review.

Die Pharmazie·2026
Same journal

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells.

Die Pharmazie·2026
Same journal

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway.

Die Pharmazie·2026
Same journal

Different Effects of the Anticonvulsant Drugs Phenytoin and Phenobarbital on Forskolin-Induced BeWo Syncytialization.

Die Pharmazie·2026
Same journal

MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases.

Die Pharmazie·2026
See all related articles

Researchers developed a stable, soluble aqueous solution of hypericin using polyvinylpyrrolidone (PVP). This innovation enables new applications for hypericin in photodynamic therapy and diagnostics, overcoming previous solubility challenges.

Area of Science:

  • Photochemistry
  • Materials Science
  • Pharmacology

Background:

  • Hypericin, derived from Hypericum perforatum, is a known photodynamic agent.
  • Existing hypericin formulations lack practical systemic or localized application methods.
  • Hypericin's poor solubility and aggregation in water limit its therapeutic and diagnostic use.

Purpose of the Study:

  • To develop a stable, aqueous formulation of hypericin for enhanced usability.
  • To create a hypericin solution suitable for photodynamic therapy (PDT) and diagnostics.
  • To investigate the properties of hypericin complexed with polyvinylpyrrolidone (PVP).

Main Methods:

  • Hypericin was non-covalently bound to polyvinylpyrrolidone (PVP) with molecular weights ranging from 10 kD to 40 kD.

Related Experiment Videos

  • The solubility, spectral properties, and fluorescence of the hypericin-PVP complex were analyzed in aqueous solutions.
  • Photostability of the complex under oxygen and broad-band light was assessed.

    • Main Results:

    • A stable, soluble aqueous solution of hypericin-PVP was successfully prepared, capable of binding over 1000 mg of hypericin per 100 g of PVP.
    • The complex exhibited characteristic absorption and fluorescence spectra, with emission around 600 nm, suitable for diagnostic applications.
    • The hypericin-PVP complex demonstrated high photostability, ensuring reproducibility in photodynamic therapy and diagnosis.

    Conclusions:

    • Hypericin forms soluble molecular chromophore complexes in water when bound to PVP.
    • This PVP complexation overcomes hypericin's insolubility, enabling its use in biological media.
    • The developed formulation facilitates new diagnostic and therapeutic applications for hypericin.